Therapeutic Product Immunogenicity Community

 View Only

  • 1.  AAPS Immunogenicity Discussion Group - March 6th | 12pm EST

    Community Leadership
    Posted 03-05-2024 08:35

    Hi all,

    Please join us for this month's AAPS Immunogenicity Discussion Group on Wednesday, March 6th at 12pm EST.

    We will hear an interesting story from the team at B2S about an ADA assay in which viral interference was observed.

    During assay development, everything looked great in the normal, healthy population.  However, introduction of the disease-state/target population was accompanied by increased background and decreased sensitivity.

    The team will walk through the evaluations and techniques that greatly improved the assay's performance in the target population, such that background/sensitivity more closely resembled that in the normal, healthy population.

    Click below and enter your email address to receive a Teams meeting calendar invite:

    Submit Email Address

    Thanks,
    Todd and Rob



    ------------------------------
    Todd Lester
    BioAgilytix | Director
    Durham, NC | [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
    ------------------------------



  • 2.  RE: AAPS Immunogenicity Discussion Group - March 6th | 12pm EST

    Community Leadership
    Posted 03-11-2024 06:02

    For those unable to join, we have saved the recording for on-demand viewing here:

    Recording

    Thanks again to Mark O'Dell and Nick Frecker!



    ------------------------------
    Robert Nelson
    Scientific Officer, Senior Director
    BioAgilytix Europe GmbH
    Hamburg Germany
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer or other entities to which I am affiliated.
    ------------------------------

    Original Message